This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Click here for VYNDAQEL®▼ (tafamidis) Prescribing Information.
Adapted from McDonagh TA, et al. Eur Heart J 2021.
*Class of recommendation.
†Level of evidence.
Class I: conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective3
Level of evidence B: recommendation based on evidence from a single randomised trial or non-randomised studies.3
Watch the video below for more information on the 2021 guidelines.
CV= cardivascular ;ESC=European Society of Cardiology ;hTTR-CA=hereditary transthyretin amyloid cardiac amyloidosis ;NYHA=New York Heart Association ;wTTR-CA=wild-type transthyretin cardiac amyloidosis
References:
Navigate the Suspect & Detect Pfizer promotional website to learn more about ATTR-CM and its diagnosis.
Learn about the efficacy of VYNDAQEL in patients with ATTR-CM
We have a team ready to support you with any queries.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024